David Seymour’s special envoy in medicines is dumping his drug company investments

28 May 2024 - Act MP Todd Stephenson is selling his investments in drug companies while labelling as “outrageous” claims ...

Read more →

Be thankful for high drug prices

4 February 2024 - If Americans weren’t overcharged, we wouldn’t have innovative treatments. ...

Read more →

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

26 January 2024 - Bristol Myers Squibb CEO Chris Boerner and another unnamed pharmaceutical CEO accepted initial invitations to testify. ...

Read more →

Generic drugs in the US are too cheap to be sustainable, experts say

19 January 2024 - Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of ...

Read more →

Drug makers raise prices of Ozempic, Mounjaro and hundreds of other drugs

18 January 2024 - Companies hiked prices of 775 brand name drugs at start of new year. ...

Read more →

Drug makers set to raise US prices on at least 500 drugs in January

29 December 2023 - Drug makers including Pfizer, Sanofi and Takeda plan to raise prices in the United States on ...

Read more →

ICER identifies most significant 2022 US drug price hikes unsupported by new clinical evidence

11 December 2023 - Of 10 high expenditure drugs that had substantial 2022 net price increases, eight were not supported by ...

Read more →

Reimbursement to pharmacies for generic drugs by Medicare Part D sponsors

5 December 2023 - Pharmacy benefit managers (PBMs) manage prescription drug benefits on behalf of health insurers; PBMs negotiate reimbursements for ...

Read more →

Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study

27 November 2023 - Of the 2556 prescription drugs marketed by 89 companies in the study period, 256 (10.0%) had a ...

Read more →

Landmark medicines deal to boost nation’s health, save NHS £14 billion, and support research investment

20 November 2023 - Pro-innovation and pro-competition agreement will introduce a new mechanism to support lower industry payment rates for more ...

Read more →

Germany, Belgium and France among those hit hardest as Commission’s Pharma-legislation proposals risk Europe losing a third of its share of global R&D by 2040

6 November 2023 - The European Federation of Pharmaceutical Industries and Associations (EFPIA) is publishing new research which assesses the ...

Read more →

The Inflation Reduction Act will lead to fewer new medicines

11 September 2023 - The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in ...

Read more →

Mid year drug price hikes are back despite Inflation Reduction Act

24 August 2023 - It’s almost a tradition. At the start and halfway points of each year, many pharmaceutical companies ...

Read more →

How advocates pushed big pharma to cut tuberculosis drug prices

14 August 2023 - The world’s best tuberculosis drug was too expensive for sufferers—until advocates and a YouTube star changed almost ...

Read more →

Don’t believe drug companies: 340B is a program worth saving

8 August 2023 - Here we go again: An op-ed column printed in this publication is yet another example of ...

Read more →